Concepedia

Publication | Open Access

Deoxynucleoside Therapy for Thymidine Kinase 2–Deficient Myopathy

113

Citations

33

References

2019

Year

Abstract

This open-label study indicates favorable side effect profiles and clinical efficacy of deoxynucleoside monophosphate and deoxynucleoside therapies for TK2 deficiency. ANN NEUROL 2019;86:293-303.

References

YearCitations

Page 1